A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

NCT06949124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis
Uterine Fibroids
Assisted Reproduction

Interventions

DRUG: SHR7280 Tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.